Ispenoral

Phenoxymethylpenicillin potassium, the active ingredient in Ispenoral, is a penicillin presented as an oral tablet for oral use. It treats susceptible bacterial infections such as streptococcal pharyngitis, otitis media, and skin infections in children and adults. GNH USA supplies Ispenoral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ispenoral (phenoxymethylpenicillin potassium) is used for infections caused by susceptible Gram‑positive bacteria. - Streptococcal pharyngitis: eradicates the causative streptococci and relieves throat symptoms. - Acute otitis media: eliminates the bacterial pathogen in the middle ear, reducing pain and inflammation. - Skin and soft‑tissue infections: clears Staphylococcus aureus or Streptococcus pyogenes from superficial skin lesions.

Adverse reactions may occur with phenoxymethylpenicillin potassium.

Common Side Effects: - Nausea: mild gastrointestinal upset after oral administration. - Diarrhea: loose stools, often self‑limiting. - Rash: mild skin erythema or urticaria. - Vaginal candidiasis: overgrowth of yeast due to altered flora. - Headache: transient, mild headache. - Abdominal pain: cramping or discomfort.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Stevens‑Johnson syndrome: rare severe skin and mucous membrane disorder. - Serum sickness‑like reaction: fever, arthralgia, rash. - Clostridioides difficile colitis: severe diarrhea due to bacterial overgrowth. - Hemolytic anemia: destruction of red blood cells in susceptible individuals. - Hepatic dysfunction: elevated liver enzymes in rare cases.

Before prescribing Ispenoral, consider the following precautions. - Allergy assessment: avoid use in patients with known penicillin hypersensitivity. - Renal impairment: adjust dosage in patients with reduced kidney function. - Hepatic disease: monitor liver function in patients with existing liver conditions. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk. - Concomitant antibiotics: avoid simultaneous use with bacteriostatic agents that may reduce efficacy. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Phenoxymethylpenicillin potassium may interact with other medicines.

Major Interactions (Avoid): - Bacteriostatic antibiotics (e.g., tetracyclines, chloramphenicol): may antagonize penicillin activity. - Probenecid: can increase penicillin plasma concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce contraceptive effectiveness; advise additional contraception. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect, requiring INR monitoring. - Methotrexate: possible increased toxicity, especially at high doses. - Allopurinol: may increase risk of rash. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of renal impairment.